Novo Nordisk AS
Kurs
Diff. Vortag in %
52 Wochen Tief
52 Wochen Hoch
- Eher Negativ
- Seit dem 27.03.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 230,90 263 | 230,90 | 263 | 13,926792 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 230,90 270 | 230,90 | 270 | 16,959064 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 230,90 250 | 230,90 | 250 | 8,29543 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 230,90 275 | 230,90 | 275 | 19,124973 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 230,90 270 | 230,90 | 270 | 16,959064 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 230,90 250 | 230,90 | 250 | 8,29543 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 230,90 270 | 230,90 | 270 | 16,959064 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 230,90 270 | 230,90 | 270 | 16,959064 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 230,90 300 | 230,90 | 300 | 29,954516 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 230,90 250 | 230,90 | 250 | 8,29543 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 230,90 270 | 230,90 | 270 | 16,959064 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 230,90 260 | 230,90 | 260 | 12,627247 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 230,90 270 | 230,90 | 270 | 16,959064 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 230,90 270 | 230,90 | 270 | 16,959064 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 230,90 400 | 230,90 | 400 | 73,272688 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 230,90 250 | 230,90 | 250 | 8,29543 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 230,90 400 | 230,90 | 400 | 73,272688 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 230,90 332 | 230,90 | 332 | 43,816331 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 230,90 340 | 230,90 | 340 | 47,281785 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 230,90 275 | 230,90 | 275 | 19,124973 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 230,90 350 | 230,90 | 350 | 51,613602 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 230,90 340 | 230,90 | 340 | 47,281785 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 230,90 275 | 230,90 | 275 | 19,124973 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 230,90 250 | 230,90 | 250 | 8,29543 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 230,90 270 | 230,90 | 270 | 16,959064 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 230,90 340 | 230,90 | 340 | 47,281785 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 230,90 340 | 230,90 | 340 | 47,281785 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 230,90 340 | 230,90 | 340 | 47,281785 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 230,90 340 | 230,90 | 340 | 47,281785 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,90 400 | 230,90 | 400 | 73,272688 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 230,90 275 | 230,90 | 275 | 19,124973 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 230,90 360 | 230,90 | 360 | 55,945419 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 230,90 360 | 230,90 | 360 | 55,945419 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 230,90 360 | 230,90 | 360 | 55,945419 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 230,90 350 | 230,90 | 350 | 51,613602 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 230,90 332 | 230,90 | 332 | 43,816331 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,90 475 | 230,90 | 475 | 105,761317 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 230,90 332 | 230,90 | 332 | 43,816331 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 230,90 350 | 230,90 | 350 | 51,613602 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 230,90 270 | 230,90 | 270 | 16,959064 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 230,90 350 | 230,90 | 350 | 51,613602 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 230,90 350 | 230,90 | 350 | 51,613602 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 230,90 360 | 230,90 | 360 | 55,945419 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 230,90 390 | 230,90 | 390 | 68,940871 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 230,90 350 | 230,90 | 350 | 51,613602 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 230,90 270 | 230,90 | 270 | 16,959064 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 230,90 436 | 230,90 | 436 | 88,86723 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 230,90 415 | 230,90 | 415 | 79,770414 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 230,90 360 | 230,90 | 360 | 55,945419 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 230,90 270 | 230,90 | 270 | 16,959064 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 230,90 390 | 230,90 | 390 | 68,940871 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 230,90 390 | 230,90 | 390 | 68,940871 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 230,90 360 | 230,90 | 360 | 55,945419 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 230,90 415 | 230,90 | 415 | 79,770414 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 230,90 475 | 230,90 | 475 | 105,761317 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 230,90 350 | 230,90 | 350 | 51,613602 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 230,90 390 | 230,90 | 390 | 68,940871 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 230,90 400 | 230,90 | 400 | 73,272688 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 230,90 400 | 230,90 | 400 | 73,272688 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 230,90 360 | 230,90 | 360 | 55,945419 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 230,90 350 | 230,90 | 350 | 51,613602 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,90 475 | 230,90 | 475 | 105,761317 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 230,90 350 | 230,90 | 350 | 51,613602 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,90 475 | 230,90 | 475 | 105,761317 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 230,90 295 | 230,90 | 295 | 27,788607 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 230,90 295 | 230,90 | 295 | 27,788607 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 230,90 350 | 230,90 | 350 | 51,613602 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 230,90 352 | 230,90 | 352 | 52,479965 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 230,90 400 | 230,90 | 400 | 73,272688 | BERENBERG | ||
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 230,90 295 | 230,90 | 295 | 27,788607 | UBS | ||
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 230,90 270 | 230,90 | 270 | 16,959064 | JEFFERIES | ||
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 230,90 375 | 230,90 | 375 | 62,443145 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 230,90 315 | 230,90 | 315 | 36,452242 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,90 475 | 230,90 | 475 | 105,761317 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.11.2025 12 Monate | 26.11.2025 | 12 Monate | 230,90 353 | 230,90 | 353 | 52,913147 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,90 475 | 230,90 | 475 | 105,761317 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 25.11.2025 0 Monate | 25.11.2025 | 0 Monate | 230,90 500 | 230,90 | 500 | 116,59086 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 230,90 500 | 230,90 | 500 | 116,59086 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 230,90 290 | 230,90 | 290 | 25,622699 | JEFFERIES | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 230,90 375 | 230,90 | 375 | 62,443145 | BARCLAYS | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 230,90 391 | 230,90 | 391 | 69,374052 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.11.2025 0 Monate | 24.11.2025 | 0 Monate | 230,90 | 230,90 | -- | DZ BANK | |||
| Novo Nordisk AS | 17.11.2025 0 Monate | 17.11.2025 | 0 Monate | 230,90 315 | 230,90 | 315 | 36,452242 | UBS | ||
| Novo Nordisk AS | 13.11.2025 0 Monate | 13.11.2025 | 0 Monate | 230,90 400 | 230,90 | 400 | 73,272688 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,90 475 | 230,90 | 475 | 105,761317 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 230,90 600 | 230,90 | 600 | 159,909032 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 230,90 | 230,90 | -- | DZ BANK | |||
| Novo Nordisk AS | 10.11.2025 0 Monate | 10.11.2025 | 0 Monate | 230,90 315 | 230,90 | 315 | 36,452242 | UBS | ||
| Novo Nordisk AS | 07.11.2025 0 Monate | 07.11.2025 | 0 Monate | 230,90 315 | 230,90 | 315 | 36,452242 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,90 600 | 230,90 | 600 | 159,909032 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 230,90 391 | 230,90 | 391 | 69,374052 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.11.2025 0 Monate | 06.11.2025 | 0 Monate | 230,90 540 | 230,90 | 540 | 133,918129 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 230,90 290 | 230,90 | 290 | 25,622699 | JEFFERIES | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 230,90 500 | 230,90 | 500 | 116,59086 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 12 Monate | 05.11.2025 | 12 Monate | 230,90 500 | 230,90 | 500 | 116,59086 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 230,90 290 | 230,90 | 290 | 25,622699 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 230,90 340 | 230,90 | 340 | 47,281785 | UBS | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 230,90 540 | 230,90 | 540 | 133,918129 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 230,90 315 | 230,90 | 315 | 36,452242 | UBS | ||
| Novo Nordisk AS | 04.11.2025 0 Monate | 04.11.2025 | 0 Monate | 230,90 540 | 230,90 | 540 | 133,918129 | BERNSTEIN RESEARCH |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 06.05.2026 | Bericht zum 1. Quartal Novo Nordisk A/S: First quarter 2026 | Novo Nordisk A/S: First quarter 2026 |
| 05.08.2026 | Bericht zum 2. Quartal Novo Nordisk A/S: Second quarter 2026 | Novo Nordisk A/S: Second quarter 2026 |
Novo Nordisk: mehr als nur Abnehmspritzen – die Chance nach dem Kursrutsch?
Der dänische Pharmakonzern Novo Nordisk dominiert mit den Blockbustern Ozempic und Wegovy (Wirkstoff Semaglutid) den milliardenschweren Markt für Diabetes- und Adipositas-Medikamente. Jüngste Gewinnwarnungen, wachsende Konkurrenz (insbesondere durch Eli Lilly) und regulatorische Unsicherheiten (Nachahmerpräparate, Preisdruck) haben die Aktie stark unter Druck gebracht.
DZ BANK Produktauswahl
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M